Market Value113,823,000
Total Holdings66
File Date2017-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ISEE / IVERIC bio Inc
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
FOMX / Foamix Pharmaceuticals Ltd.
ZGNX / Zogenix Inc
CYNA / Cynapsus Therapeutics Inc.
US64052L1061 / Neos Therapeutics, Inc.
ARQL / ArQule, Inc.
INNL / Innocoll Holdings plc
AGTC / Applied Genetic Technologies Corp
PTN / Palatin Technologies, Inc.
ABUS / Arbutus Biopharma Corporation
RDUS / Radius Recycling, Inc.
VIRX / Viracta Therapeutics, Inc.
CVM / CEL-SCI Corporation
NLTX / Neoleukin Therapeutics, Inc.
CRDC / Cardica, Inc.
IMDZ / Immune Design Corp.
ADXS / Ayala Pharmaceuticals, Inc.
JNJ / Johnson & Johnson
ABEO / Abeona Therapeutics Inc.
TMBR / Timber Pharmaceuticals Inc
ALDR / Alder BioPharmaceuticals, Inc.
ELOS / Syneron Medical Ltd.
74365AAB7 / Protalix BioTherapeutics, Inc. Bonds 4.5% 9/15/18
US0909311062 / BioSpecifics Technologies Corp.
TSRO / TESARO, Inc.
WINT / Windtree Therapeutics, Inc.
DSCI / Derma Sciences, Inc.
LOXO / Loxo Oncology, Inc.
EXAC / Exactech, Inc.
CBIO / Crescent Biopharma, Inc.
EIGR / Eiger BioPharmaceuticals, Inc.
NXTM / NxStage Medical, Inc.
NDRM / NeuroDerm Ltd.
NVDQ / ETF Opportunities Trust - T-Rex 2X Inverse NVIDIA Daily Target ETF
RCKT / Rocket Pharmaceuticals, Inc.
45780VAB8 / Inotek Pharmaceuticals Corporation Bonds 5.75% 8/1/2021
45784PAD3 / Insulet Corp. Bond
US46333XAD03 / Ironwood Pharmaceuticals, Inc. DBCV 2.250% 6/1
NERV / Minerva Neurosciences, Inc.
EPIX / ESSA Pharma Inc.
CNCE / Concert Pharmaceuticals Inc
VTAE / Vitae Pharmaceuticals, Inc.
/ Array BioPharma, Inc.
GNVC / GenVec, Inc.
CYAD / Celyad Oncology - ADR
US00448Q2012 / Achillion Pharmaceuticals, Inc.
VSCI /
SGYPQ / SYNERGY PHARMACEUTICALS INC DEL
US0906721065 / BioTelemetry, Inc.
SPNC / Spectranetics Corp. (The)
DERM / Journey Medical Corporation
DRNA / Dicerna Pharmaceuticals Inc
/ Immunomedics, Inc.
RGLS / Regulus Therapeutics Inc.
PIRS / Pieris Pharmaceuticals, Inc.
CHEK / Check-Cap Ltd.
BGNE / BeiGene, Ltd. - Depositary Receipt (Common Stock)
ALPN / Alpine Immune Sciences, Inc.
AERI / Aerie Pharmaceuticals Inc
FSTX / F-star Therapeutics Inc
RIGL / Rigel Pharmaceuticals, Inc.
BPMC / Blueprint Medicines Corporation
AGLE / Aeglea BioTherapeutics Inc
RSLS / ReShape Lifesciences Inc.
ARDX / Ardelyx, Inc.
IBB / iShares Trust - iShares Biotechnology ETF
CYTK / Cytokinetics, Incorporated
NBIX / Neurocrine Biosciences, Inc.
SCYX / SCYNEXIS, Inc.
BLUE / bluebird bio, Inc.
QURE / uniQure N.V.
CARA / Cara Therapeutics, Inc.
AVGR / Avinger, Inc.
MGNX / MacroGenics, Inc.
PTGX / Protagonist Therapeutics, Inc.
MASI / Masimo Corporation
CDTX / Cidara Therapeutics, Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
TNDM / Tandem Diabetes Care, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
STXS / Stereotaxis, Inc.
ATRC / AtriCure, Inc.
PODD / Insulet Corporation
XENE / Xenon Pharmaceuticals Inc.